# Investigating Neurocognitive Disorders Epidemiology

> **NCT06375213** · — · RECRUITING · sponsor: **King Chulalongkorn Memorial Hospital** · enrollment: 990 (estimated)

## Conditions studied

- Dementia
- Cognitive Decline
- Alzheimer Disease

## Interventions

- **DIAGNOSTIC_TEST:** Plasma tau phosphorylated at Thr217
- **OTHER:** Neurocognitive examination

## Key facts

- **NCT ID:** NCT06375213
- **Lead sponsor:** King Chulalongkorn Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-24
- **Primary completion:** 2035-08-24
- **Final completion:** 2035-08-24
- **Target enrollment:** 990 (ESTIMATED)
- **Last updated:** 2024-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06375213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06375213, "Investigating Neurocognitive Disorders Epidemiology". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06375213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*